Global Monogenic Disease Testing Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Monogenic Disease Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Monogenic Disease Testing players cover Celera Support Services, Abbott, ELITech Group, Auto Genomics and PerkinElmer and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Monogenic Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Monogenic Disease Testing market, with both quantitative and qualitative data, to help readers understand how the Monogenic Disease Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Monogenic Disease Testing market and forecasts the market size by Type (Carrier Testing, Diagnostic Testing and New-Born Screening), by Application (Hospitals, Clinics and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Monogenic Disease Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Monogenic Disease Testing market size and CAGR, Monogenic Disease Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Monogenic Disease Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Monogenic Disease Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Monogenic Disease Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer and Bio-Rad Laboratories, etc.
Chapter 14: Research Findings and Conclusion
The global market for Monogenic Disease Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Monogenic Disease Testing players cover Celera Support Services, Abbott, ELITech Group, Auto Genomics and PerkinElmer and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Monogenic Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Monogenic Disease Testing market, with both quantitative and qualitative data, to help readers understand how the Monogenic Disease Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Monogenic Disease Testing market and forecasts the market size by Type (Carrier Testing, Diagnostic Testing and New-Born Screening), by Application (Hospitals, Clinics and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Carrier Testing
- Diagnostic Testing
- New-Born Screening
- Predictive and Pre-Symptomatic Testing
- Prenatal Testing
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Celera Support Services
- Abbott
- ELITech Group
- Auto Genomics
- PerkinElmer
- Bio-Rad Laboratories
Chapter 1: Scope of Monogenic Disease Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Monogenic Disease Testing market size and CAGR, Monogenic Disease Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Monogenic Disease Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Monogenic Disease Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Monogenic Disease Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer and Bio-Rad Laboratories, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Monogenic Disease Testing Market Size 2017-2028
2.1.2 Monogenic Disease Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Monogenic Disease Testing Segment by Type
2.2.1 Carrier Testing
2.2.2 Diagnostic Testing
2.2.3 New-Born Screening
2.2.4 Predictive and Pre-Symptomatic Testing
2.2.5 Prenatal Testing
2.3 Monogenic Disease Testing Market Size by Type
2.3.1 Monogenic Disease Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
2.4 Monogenic Disease Testing Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Monogenic Disease Testing Market Size by Application
2.5.1 Monogenic Disease Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
3 MONOGENIC DISEASE TESTING MARKET SIZE BY PLAYER
3.1 Monogenic Disease Testing Market Size Market Share by Players
3.1.1 Global Monogenic Disease Testing Revenue by Players (2020-2022)
3.1.2 Global Monogenic Disease Testing Revenue Market Share by Players (2020-2022)
3.2 Global Monogenic Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MONOGENIC DISEASE TESTING BY REGIONS
4.1 Monogenic Disease Testing Market Size by Regions (2017-2022)
4.2 Americas Monogenic Disease Testing Market Size Growth (2017-2022)
4.3 APAC Monogenic Disease Testing Market Size Growth (2017-2022)
4.4 Europe Monogenic Disease Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Monogenic Disease Testing Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Monogenic Disease Testing Market Size by Country (2017-2022)
5.2 Americas Monogenic Disease Testing Market Size by Type (2017-2022)
5.3 Americas Monogenic Disease Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monogenic Disease Testing Market Size by Region (2017-2022)
6.2 APAC Monogenic Disease Testing Market Size by Type (2017-2022)
6.3 APAC Monogenic Disease Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Monogenic Disease Testing by Country (2017-2022)
7.2 Europe Monogenic Disease Testing Market Size by Type (2017-2022)
7.3 Europe Monogenic Disease Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Monogenic Disease Testing by Region (2017-2022)
8.2 Middle East & Africa Monogenic Disease Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Monogenic Disease Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MONOGENIC DISEASE TESTING MARKET FORECAST
10.1 Global Monogenic Disease Testing Forecast by Regions (2023-2028)
10.1.1 Global Monogenic Disease Testing Forecast by Regions (2023-2028)
10.1.2 Americas Monogenic Disease Testing Forecast
10.1.3 APAC Monogenic Disease Testing Forecast
10.1.4 Europe Monogenic Disease Testing Forecast
10.1.5 Middle East & Africa Monogenic Disease Testing Forecast
10.2 Americas Monogenic Disease Testing Forecast by Country (2023-2028)
10.2.1 United States Monogenic Disease Testing Market Forecast
10.2.2 Canada Monogenic Disease Testing Market Forecast
10.2.3 Mexico Monogenic Disease Testing Market Forecast
10.2.4 Brazil Monogenic Disease Testing Market Forecast
10.3 APAC Monogenic Disease Testing Forecast by Region (2023-2028)
10.3.1 China Monogenic Disease Testing Market Forecast
10.3.2 Japan Monogenic Disease Testing Market Forecast
10.3.3 Korea Monogenic Disease Testing Market Forecast
10.3.4 Southeast Asia Monogenic Disease Testing Market Forecast
10.3.5 India Monogenic Disease Testing Market Forecast
10.3.6 Australia Monogenic Disease Testing Market Forecast
10.4 Europe Monogenic Disease Testing Forecast by Country (2023-2028)
10.4.1 Germany Monogenic Disease Testing Market Forecast
10.4.2 France Monogenic Disease Testing Market Forecast
10.4.3 UK Monogenic Disease Testing Market Forecast
10.4.4 Italy Monogenic Disease Testing Market Forecast
10.4.5 Russia Monogenic Disease Testing Market Forecast
10.5 Middle East & Africa Monogenic Disease Testing Forecast by Region (2023-2028)
10.5.1 Egypt Monogenic Disease Testing Market Forecast
10.5.2 South Africa Monogenic Disease Testing Market Forecast
10.5.3 Israel Monogenic Disease Testing Market Forecast
10.5.4 Turkey Monogenic Disease Testing Market Forecast
10.5.5 GCC Countries Monogenic Disease Testing Market Forecast
10.6 Global Monogenic Disease Testing Forecast by Type (2023-2028)
10.7 Global Monogenic Disease Testing Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Celera Support Services
11.1.1 Celera Support Services Company Information
11.1.2 Celera Support Services Monogenic Disease Testing Product Offered
11.1.3 Celera Support Services Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Celera Support Services Main Business Overview
11.1.5 Celera Support Services Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Monogenic Disease Testing Product Offered
11.2.3 Abbott Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 ELITech Group
11.3.1 ELITech Group Company Information
11.3.2 ELITech Group Monogenic Disease Testing Product Offered
11.3.3 ELITech Group Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 ELITech Group Main Business Overview
11.3.5 ELITech Group Latest Developments
11.4 Auto Genomics
11.4.1 Auto Genomics Company Information
11.4.2 Auto Genomics Monogenic Disease Testing Product Offered
11.4.3 Auto Genomics Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Auto Genomics Main Business Overview
11.4.5 Auto Genomics Latest Developments
11.5 PerkinElmer
11.5.1 PerkinElmer Company Information
11.5.2 PerkinElmer Monogenic Disease Testing Product Offered
11.5.3 PerkinElmer Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 PerkinElmer Main Business Overview
11.5.5 PerkinElmer Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories Monogenic Disease Testing Product Offered
11.6.3 Bio-Rad Laboratories Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Monogenic Disease Testing Market Size 2017-2028
2.1.2 Monogenic Disease Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Monogenic Disease Testing Segment by Type
2.2.1 Carrier Testing
2.2.2 Diagnostic Testing
2.2.3 New-Born Screening
2.2.4 Predictive and Pre-Symptomatic Testing
2.2.5 Prenatal Testing
2.3 Monogenic Disease Testing Market Size by Type
2.3.1 Monogenic Disease Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
2.4 Monogenic Disease Testing Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Monogenic Disease Testing Market Size by Application
2.5.1 Monogenic Disease Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
3 MONOGENIC DISEASE TESTING MARKET SIZE BY PLAYER
3.1 Monogenic Disease Testing Market Size Market Share by Players
3.1.1 Global Monogenic Disease Testing Revenue by Players (2020-2022)
3.1.2 Global Monogenic Disease Testing Revenue Market Share by Players (2020-2022)
3.2 Global Monogenic Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MONOGENIC DISEASE TESTING BY REGIONS
4.1 Monogenic Disease Testing Market Size by Regions (2017-2022)
4.2 Americas Monogenic Disease Testing Market Size Growth (2017-2022)
4.3 APAC Monogenic Disease Testing Market Size Growth (2017-2022)
4.4 Europe Monogenic Disease Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Monogenic Disease Testing Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Monogenic Disease Testing Market Size by Country (2017-2022)
5.2 Americas Monogenic Disease Testing Market Size by Type (2017-2022)
5.3 Americas Monogenic Disease Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monogenic Disease Testing Market Size by Region (2017-2022)
6.2 APAC Monogenic Disease Testing Market Size by Type (2017-2022)
6.3 APAC Monogenic Disease Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Monogenic Disease Testing by Country (2017-2022)
7.2 Europe Monogenic Disease Testing Market Size by Type (2017-2022)
7.3 Europe Monogenic Disease Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Monogenic Disease Testing by Region (2017-2022)
8.2 Middle East & Africa Monogenic Disease Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Monogenic Disease Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MONOGENIC DISEASE TESTING MARKET FORECAST
10.1 Global Monogenic Disease Testing Forecast by Regions (2023-2028)
10.1.1 Global Monogenic Disease Testing Forecast by Regions (2023-2028)
10.1.2 Americas Monogenic Disease Testing Forecast
10.1.3 APAC Monogenic Disease Testing Forecast
10.1.4 Europe Monogenic Disease Testing Forecast
10.1.5 Middle East & Africa Monogenic Disease Testing Forecast
10.2 Americas Monogenic Disease Testing Forecast by Country (2023-2028)
10.2.1 United States Monogenic Disease Testing Market Forecast
10.2.2 Canada Monogenic Disease Testing Market Forecast
10.2.3 Mexico Monogenic Disease Testing Market Forecast
10.2.4 Brazil Monogenic Disease Testing Market Forecast
10.3 APAC Monogenic Disease Testing Forecast by Region (2023-2028)
10.3.1 China Monogenic Disease Testing Market Forecast
10.3.2 Japan Monogenic Disease Testing Market Forecast
10.3.3 Korea Monogenic Disease Testing Market Forecast
10.3.4 Southeast Asia Monogenic Disease Testing Market Forecast
10.3.5 India Monogenic Disease Testing Market Forecast
10.3.6 Australia Monogenic Disease Testing Market Forecast
10.4 Europe Monogenic Disease Testing Forecast by Country (2023-2028)
10.4.1 Germany Monogenic Disease Testing Market Forecast
10.4.2 France Monogenic Disease Testing Market Forecast
10.4.3 UK Monogenic Disease Testing Market Forecast
10.4.4 Italy Monogenic Disease Testing Market Forecast
10.4.5 Russia Monogenic Disease Testing Market Forecast
10.5 Middle East & Africa Monogenic Disease Testing Forecast by Region (2023-2028)
10.5.1 Egypt Monogenic Disease Testing Market Forecast
10.5.2 South Africa Monogenic Disease Testing Market Forecast
10.5.3 Israel Monogenic Disease Testing Market Forecast
10.5.4 Turkey Monogenic Disease Testing Market Forecast
10.5.5 GCC Countries Monogenic Disease Testing Market Forecast
10.6 Global Monogenic Disease Testing Forecast by Type (2023-2028)
10.7 Global Monogenic Disease Testing Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Celera Support Services
11.1.1 Celera Support Services Company Information
11.1.2 Celera Support Services Monogenic Disease Testing Product Offered
11.1.3 Celera Support Services Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Celera Support Services Main Business Overview
11.1.5 Celera Support Services Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Monogenic Disease Testing Product Offered
11.2.3 Abbott Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 ELITech Group
11.3.1 ELITech Group Company Information
11.3.2 ELITech Group Monogenic Disease Testing Product Offered
11.3.3 ELITech Group Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 ELITech Group Main Business Overview
11.3.5 ELITech Group Latest Developments
11.4 Auto Genomics
11.4.1 Auto Genomics Company Information
11.4.2 Auto Genomics Monogenic Disease Testing Product Offered
11.4.3 Auto Genomics Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Auto Genomics Main Business Overview
11.4.5 Auto Genomics Latest Developments
11.5 PerkinElmer
11.5.1 PerkinElmer Company Information
11.5.2 PerkinElmer Monogenic Disease Testing Product Offered
11.5.3 PerkinElmer Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 PerkinElmer Main Business Overview
11.5.5 PerkinElmer Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories Monogenic Disease Testing Product Offered
11.6.3 Bio-Rad Laboratories Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Monogenic Disease Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Carrier Testing
Table 3. Major Players of Diagnostic Testing
Table 4. Major Players of New-Born Screening
Table 5. Major Players of Predictive and Pre-Symptomatic Testing
Table 6. Major Players of Prenatal Testing
Table 7. Monogenic Disease Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 10. Monogenic Disease Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 13. Global Monogenic Disease Testing Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Monogenic Disease Testing Revenue Market Share by Player (2020-2022)
Table 15. Monogenic Disease Testing Key Players Head office and Products Offered
Table 16. Monogenic Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Monogenic Disease Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Monogenic Disease Testing Market Size Market Share by Regions (2017-2022)
Table 21. Americas Monogenic Disease Testing Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Monogenic Disease Testing Market Size Market Share by Country (2017-2022)
Table 23. Americas Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 25. Americas Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 27. APAC Monogenic Disease Testing Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Monogenic Disease Testing Market Size Market Share by Region (2017-2022)
Table 29. APAC Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 31. APAC Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 33. Europe Monogenic Disease Testing Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Monogenic Disease Testing Market Size Market Share by Country (2017-2022)
Table 35. Europe Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 37. Europe Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Monogenic Disease Testing Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Monogenic Disease Testing
Table 46. Key Market Challenges & Risks of Monogenic Disease Testing
Table 47. Key Industry Trends of Monogenic Disease Testing
Table 48. Global Monogenic Disease Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Monogenic Disease Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Monogenic Disease Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Monogenic Disease Testing Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Monogenic Disease Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Monogenic Disease Testing Market Size Market Share Forecast by Application (2023-2028)
Table 54. Celera Support Services Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 55. Celera Support Services Monogenic Disease Testing Product Offered
Table 56. Celera Support Services Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Celera Support Services Main Business
Table 58. Celera Support Services Latest Developments
Table 59. Abbott Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 60. Abbott Monogenic Disease Testing Product Offered
Table 61. Abbott Main Business
Table 62. Abbott Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Abbott Latest Developments
Table 64. ELITech Group Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 65. ELITech Group Monogenic Disease Testing Product Offered
Table 66. ELITech Group Main Business
Table 67. ELITech Group Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. ELITech Group Latest Developments
Table 69. Auto Genomics Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 70. Auto Genomics Monogenic Disease Testing Product Offered
Table 71. Auto Genomics Main Business
Table 72. Auto Genomics Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Auto Genomics Latest Developments
Table 74. PerkinElmer Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 75. PerkinElmer Monogenic Disease Testing Product Offered
Table 76. PerkinElmer Main Business
Table 77. PerkinElmer Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. PerkinElmer Latest Developments
Table 79. Bio-Rad Laboratories Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 80. Bio-Rad Laboratories Monogenic Disease Testing Product Offered
Table 81. Bio-Rad Laboratories Main Business
Table 82. Bio-Rad Laboratories Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Bio-Rad Laboratories Latest Developments
Table 1. Monogenic Disease Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Carrier Testing
Table 3. Major Players of Diagnostic Testing
Table 4. Major Players of New-Born Screening
Table 5. Major Players of Predictive and Pre-Symptomatic Testing
Table 6. Major Players of Prenatal Testing
Table 7. Monogenic Disease Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 10. Monogenic Disease Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 13. Global Monogenic Disease Testing Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Monogenic Disease Testing Revenue Market Share by Player (2020-2022)
Table 15. Monogenic Disease Testing Key Players Head office and Products Offered
Table 16. Monogenic Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Monogenic Disease Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Monogenic Disease Testing Market Size Market Share by Regions (2017-2022)
Table 21. Americas Monogenic Disease Testing Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Monogenic Disease Testing Market Size Market Share by Country (2017-2022)
Table 23. Americas Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 25. Americas Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 27. APAC Monogenic Disease Testing Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Monogenic Disease Testing Market Size Market Share by Region (2017-2022)
Table 29. APAC Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 31. APAC Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 33. Europe Monogenic Disease Testing Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Monogenic Disease Testing Market Size Market Share by Country (2017-2022)
Table 35. Europe Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 37. Europe Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Monogenic Disease Testing Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Monogenic Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Monogenic Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Monogenic Disease Testing
Table 46. Key Market Challenges & Risks of Monogenic Disease Testing
Table 47. Key Industry Trends of Monogenic Disease Testing
Table 48. Global Monogenic Disease Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Monogenic Disease Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Monogenic Disease Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Monogenic Disease Testing Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Monogenic Disease Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Monogenic Disease Testing Market Size Market Share Forecast by Application (2023-2028)
Table 54. Celera Support Services Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 55. Celera Support Services Monogenic Disease Testing Product Offered
Table 56. Celera Support Services Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Celera Support Services Main Business
Table 58. Celera Support Services Latest Developments
Table 59. Abbott Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 60. Abbott Monogenic Disease Testing Product Offered
Table 61. Abbott Main Business
Table 62. Abbott Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Abbott Latest Developments
Table 64. ELITech Group Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 65. ELITech Group Monogenic Disease Testing Product Offered
Table 66. ELITech Group Main Business
Table 67. ELITech Group Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. ELITech Group Latest Developments
Table 69. Auto Genomics Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 70. Auto Genomics Monogenic Disease Testing Product Offered
Table 71. Auto Genomics Main Business
Table 72. Auto Genomics Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Auto Genomics Latest Developments
Table 74. PerkinElmer Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 75. PerkinElmer Monogenic Disease Testing Product Offered
Table 76. PerkinElmer Main Business
Table 77. PerkinElmer Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. PerkinElmer Latest Developments
Table 79. Bio-Rad Laboratories Details, Company Type, Monogenic Disease Testing Area Served and Its Competitors
Table 80. Bio-Rad Laboratories Monogenic Disease Testing Product Offered
Table 81. Bio-Rad Laboratories Main Business
Table 82. Bio-Rad Laboratories Monogenic Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Bio-Rad Laboratories Latest Developments
LIST OF FIGURES
LIST OF FIGURES
Figure 1. Monogenic Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Monogenic Disease Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Monogenic Disease Testing Market Size Market Share by Type in 2021
Figure 7. Monogenic Disease Testing in Hospitals
Figure 8. Global Monogenic Disease Testing Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Monogenic Disease Testing in Clinics
Figure 10. Global Monogenic Disease Testing Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Monogenic Disease Testing in Others
Figure 12. Global Monogenic Disease Testing Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 14. Global Monogenic Disease Testing Revenue Market Share by Player in 2021
Figure 15. Global Monogenic Disease Testing Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Monogenic Disease Testing Market Size 2017-2022 ($ Millions)
Figure 17. APAC Monogenic Disease Testing Market Size 2017-2022 ($ Millions)
Figure 18. Europe Monogenic Disease Testing Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Monogenic Disease Testing Market Size 2017-2022 ($ Millions)
Figure 20. Americas Monogenic Disease Testing Value Market Share by Country in 2021
Figure 21. Americas Monogenic Disease Testing Consumption Market Share by Type in 2021
Figure 22. Americas Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 23. United States Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Monogenic Disease Testing Market Size Market Share by Region in 2021
Figure 28. APAC Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 29. China Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Monogenic Disease Testing Market Size Market Share by Country in 2021
Figure 36. Europe Monogenic Disease Testing Market Size Market Share by Type in 2021
Figure 37. Europe Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 38. Germany Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 46. Egypt Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 52. APAC Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 53. Europe Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 55. United States Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 56. Canada Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 59. China Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 60. Japan Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 61. Korea Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 63. India Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 64. Australia Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 65. Germany Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 66. France Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 67. UK Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 68. Italy Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 69. Russia Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 70. Spain Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 73. Israel Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
LIST OF FIGURES
Figure 1. Monogenic Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Monogenic Disease Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Monogenic Disease Testing Market Size Market Share by Type in 2021
Figure 7. Monogenic Disease Testing in Hospitals
Figure 8. Global Monogenic Disease Testing Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Monogenic Disease Testing in Clinics
Figure 10. Global Monogenic Disease Testing Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Monogenic Disease Testing in Others
Figure 12. Global Monogenic Disease Testing Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 14. Global Monogenic Disease Testing Revenue Market Share by Player in 2021
Figure 15. Global Monogenic Disease Testing Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Monogenic Disease Testing Market Size 2017-2022 ($ Millions)
Figure 17. APAC Monogenic Disease Testing Market Size 2017-2022 ($ Millions)
Figure 18. Europe Monogenic Disease Testing Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Monogenic Disease Testing Market Size 2017-2022 ($ Millions)
Figure 20. Americas Monogenic Disease Testing Value Market Share by Country in 2021
Figure 21. Americas Monogenic Disease Testing Consumption Market Share by Type in 2021
Figure 22. Americas Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 23. United States Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Monogenic Disease Testing Market Size Market Share by Region in 2021
Figure 28. APAC Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 29. China Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Monogenic Disease Testing Market Size Market Share by Country in 2021
Figure 36. Europe Monogenic Disease Testing Market Size Market Share by Type in 2021
Figure 37. Europe Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 38. Germany Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Monogenic Disease Testing Market Size Market Share by Application in 2021
Figure 46. Egypt Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Monogenic Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 52. APAC Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 53. Europe Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 55. United States Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 56. Canada Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 59. China Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 60. Japan Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 61. Korea Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 63. India Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 64. Australia Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 65. Germany Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 66. France Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 67. UK Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 68. Italy Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 69. Russia Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 70. Spain Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 73. Israel Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Monogenic Disease Testing Market Size 2023-2028 ($ Millions)
